These carefully combined services enable us to provide our customers with a complete service on all the stages of their drug development programs, from the early planning phase to final execution.

Venn Life Sciences features offices in Breda (Netherlands) and Paris (France) that offer expertise and capabilities in: CMC, Non-Clinical, Clinical Pharmacology and Development, Statistics, Study design and Methodology, Data Management, RTSM and Regulatory Affairs across a wide variety of therapeutic areas.

Long term partnerships

Providing comprehensive added-value services in the long-term.

Anticipating customer needs

Development and integration of new services anticipated by customer needs.

Operational Excellence

Ensuring operational excellence across our service lines

For over 25 years we have been a trusted partner to the life science industry. In recent years, we have developed our services and offering by acquiring Kinesis Pharma in 2015 and becoming part of Open Orphan, a rapidly growing niche CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. In 2022, Open Orphan has rebranded to hVIVO. Venn Life Sciences has longevity within the industry and has a team of motivated experts, which combined expedites the development of Biopharma projects worldwide.